Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

A 40-Year Natural History Study of Overall Survival and Primary Causes of Death in Systemic Light Chain (AL) Amyloidosis

Andrew Staron, Luke Zheng, Gheorghe Doros, Lawreen H Connors, Vaishali Sanchorawala

Blood (2021) 138 (Supplement 1): 155.

https://doi.org/10.1182/blood-2021-151804

Published: 2021

Journal Articles

Racial and Ethnic Disparities in Systemic AL Amyloidosis: Examining Differences in Clinical Presentation and Outcomes

Andrew Staron, Lawreen H Connors, PhD, Luke Zheng, BS, Gheorghe Doros, PhD, Vaishali Sanchorawala, MD

Blood (2020) 136 (Supplement 1): 51.

https://doi.org/10.1182/blood-2020-139751

Published: 2020

Journal Articles

The Changing Face of Amyloidosis Referrals at a Tertiary Center over the Past 3 Decades

Andrew Staron, Lawreen H Connors, Frederick L Ruberg, John L. Berk, Lisa M Mendelson, Vaishali Sanchorawala, MD

Blood (2018) 132 (Supplement 1): 5536.

https://doi.org/10.1182/blood-2018-99-112193

Published: 2018

Journal Articles

Doxycycline reduces fibril formation in a transgenic mouse model of AL amyloidosis

Jennifer Ellis Ward, Ruiyi Ren, Gianluca Toraldo, Pam SooHoo, Jian Guan, Carl O'Hara, Ravi Jasuja, Vickery Trinkaus-Randall, Ronglih Liao, Lawreen H. Connors, David C. Seldin

Blood (2011) 118 (25): 6610–6617.

https://doi.org/10.1182/blood-2011-04-351643

Published: 2011

Journal Articles

Doxycycline Reduces Fibril Formation in a Transgenic Mouse Model of AL Amyloidosis

David C Seldin, MD, PhD, Jennifer Ward, PhD, Ruiyi Ren, MSc, Gianluca Toraldo, PhD, Pamela T SooHoo, BA, Jian Guan, BS, Carl O'Hara, Ravi Jasuja, PhD, Vickery Trinkaus-Randall, PhD, Ronglih Liao, PhD, Lawreen H Connors, PhD

Blood (2011) 118 (21): 1837.

https://doi.org/10.1182/blood.V118.21.1837.1837

Published: 2011

Journal Articles

Expression of Human Amyloidogenic Immunoglobulin Light Chains in Mice Leads to Organ Toxicity.

Jennifer E. Ward, PhD, Daniel Brenner, PhD, Lei Cui, PhD, Ronglih Liao, PhD, Lawreen H. Connors, PhD, Pam Soo Hoo, BS, Jeremy Eberhard, BA, Thomas Christensen, PhD, Carl O’Hara, MD, Martha Skinner, MD, David C. Seldin, MD/PhD

Blood (2005) 106 (11): 3412.

https://doi.org/10.1182/blood.V106.11.3412.3412

Published: 2005

NARROW

A 40-Year Natural History Study of Overall Survival and Primary Causes of Death in Systemic Light Chain (AL) Amyloidosis

Racial and Ethnic Disparities in Systemic AL Amyloidosis: Examining Differences in Clinical Presentation and Outcomes

The Changing Face of Amyloidosis Referrals at a Tertiary Center over the Past 3 Decades

Doxycycline reduces fibril formation in a transgenic mouse model of AL amyloidosis

Doxycycline Reduces Fibril Formation in a Transgenic Mouse Model of AL Amyloidosis

Expression of Human Amyloidogenic Immunoglobulin Light Chains in Mice Leads to Organ Toxicity.

Email alerts

ASH Publications

American Society of Hematology

A 40-Year Natural History Study of Overall Survival and Primary Causes of Death in Systemic Light Chain (AL) Amyloidosis

Racial and Ethnic Disparities in Systemic AL Amyloidosis: Examining Differences in Clinical Presentation and Outcomes

The Changing Face of Amyloidosis Referrals at a Tertiary Center over the Past 3 Decades

Doxycycline reduces fibril formation in a transgenic mouse model of AL amyloidosis

Doxycycline Reduces Fibril Formation in a Transgenic Mouse Model of AL Amyloidosis

Expression of Human Amyloidogenic Immunoglobulin Light Chains in Mice Leads to Organ Toxicity.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only